EichorEICHOR
Study identifier: NCT07373366 Synced from ClinicalTrials.gov · August 03, 2026
● Recruiting

Assessment of Noninvasive Neuromodulation in a Group of Traumatic Brain Injured Patients and Healthy Volunteers

Condition: Traumatic Brain Injury  ·  Sponsor: University of Sao Paulo

PhasePhase 2
Planned participants60
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

Background: Severe traumatic brain injury, particularly diffuse axonal injury (DAI), often leads to lasting neurological issues. Cerebral dysfunction in DAI can be evaluated by monitoring cerebral electrical activity (CEA) through EEG. The radio electric asymmetric conveyer (REAC) is a noninvasive method designed to rebalance cellular polarity via endogenous bioelectric fields and modulate CEA. This technique may alter CEA, which can be detected using quantitative EEG (qEEG). Objective: To assess qEEG changes following DAI and brain wave alterations after a REAC protocol in this group. Methods: In this prospective, randomized, double-blind clinical trial, DAI patients will be assigned to active or sham groups for 19 sessions of either true or sham REAC following ICU discharge. Interventions include one Neuro Postural Optimization session and 18 NPPO-BWO-G sessions (up to four per day). The main outcome is to evaluate changes in qEEG patterns through population brain electrical mapping after REAC therapies.

This description comes directly from the study's public registry record.

Talk to the study team

Sérgio Brasil, MD. PhD.  ·  +5511981210990  ·  sbrasil@alumni.usp.br

Alessandra C Renck, MD. PhD.  ·  +5511981211114  ·  alerenck@alumni.usp.br

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital das Clínicas da FM-USPSão Paulo, São Paulo, BrazilRecruiting

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →